Evidence map›Paper›PMID 35628063›Full record

ArticleHealthcare (Basel, Switzerland)2022

Determinants of the Limpopo Province of South Africa's Response to COVID-19: A Mixed Methods Protocol to Analyze and Share Lessons Learned.

Sogo F Matlala, Takalani G Tshitangano, Musa E Setati, Naledzani J Ramalivhana, Peter M Mphekgwana

Abstract read
In one paragraph

Article in Healthcare (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sogo F MatlalaDepartment of Public Health, University of Limpopo, Sovenga, Polokwane 0727, South Africa.ORCID 0000-0002-2291-6779
Takalani G TshitanganoDepartment of Public Health, University of Venda, Thohoyandou 0950, South Africa.
Musa E SetatiDepartment of Health, University of Limpopo, Polokwane 0700, South Africa.ORCID 0000-0002-5164-344X
Naledzani J RamalivhanaDepartment of Pharmacy, University of Limpopo, Sovenga, Polokwane 0727, South Africa.
Peter M MphekgwanaResearch Administration and Development, University of Limpopo, Sovenga, Polokwane 0727, South Africa.ORCID 0000-0002-3068-9406

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 is a priority health research agenda item in South Africa. The World Health Organization declared the COVID-19 outbreak as a Public Health Emergency of International Concern, which requires all countries to respond and share data with others. Responses included the implementation of measures to reduce the spread of COVID-19 and protect health systems from being overwhelmed by seriously ill patients. Each country was mandated to assess its own risk and rapidly implement the necessary measures to reduce COVID-19 transmission and minimize its impact. Countries were further encouraged to share their experiences of responding to the COVID-19 pandemic. Media reports in South Africa suggest that the Limpopo Department of Health implemented a successful COVID-19 response. This study aims to analyze, document and publish those successes to make them accessible to other researchers and public health practitioners. The study will also allow for the participation of public health students to meet the requirements of their postgraduate degrees. This convergent parallel mixed method study will collect secondary data of responses to COVID-19 by the Limpopo Department of Health from the records the department keeps. Quantitative and qualitative data detailing activities and statistics describing facilitators and barriers to implementation of COVID-19 response from March 2020 will be extracted from records.

Indexed as

COVID-19lessons learnedsecondary data

Identifiers

PMID35628063
PMCPMC9141813

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.